Wegovy side effects: A complete guide for UK patients

What is Wegovy?

Wegovy is a brand name for semaglutide, a prescription medication licensed in the UK for chronic weight management. It belongs to a class of drugs known as GLP-1 receptor agonists, and works by mimicking a naturally occurring hormone that targets areas of the brain regulating appetite and food intake. By increasing feelings of fullness and slowing the rate at which the stomach empties, it helps people consume fewer calories over time.

In the UK, Wegovy is licensed for adults with a BMI of 30 kg/m² or above, or 27 kg/m² or above with at least one weight-related health condition such as hypertension or type 2 diabetes. It is administered once a week via a pre-filled injection pen.

What are Wegovy side effects?

As the body adjusts to semaglutide, various side effects may arise. The most common are gastrointestinal in nature and are usually most noticeable during the 16-week titration phase as the dose is gradually increased.

Clinical trials, including the landmark STEP programme, found that over 80% of participants reported at least one side effect, though the vast majority were mild to moderate. In the UK, Wegovy carries the Black Triangle symbol (▼), meaning the MHRA actively encourages the submission of Yellow Card reports for any suspected side effects to build the long-term safety evidence base. For comprehensive details on known risks, always refer to the latest patient information leaflet available at medicines.org.uk.

Most common side effects: Frequency and data

Based on clinical trial data, Wegovy side effects are categorised by frequency. The breakdown below is drawn from the Electronic Medicines Compendium (EMC) and the SELECT trial data.

Very common side effects (affecting more than 1 in 10 people)

• Nausea: reported by approximately 44% of patients
• Diarrhoea: reported by approximately 30% of patients
• Vomiting: reported by approximately 24% of patients
• Constipation: reported by approximately 24% of patients
• Fatigue: reported by more than 10% of patients

Common side effects (affecting up to 1 in 10 people)

• Headache: reported by approximately 14% of patients
• Dizziness: reported by approximately 8% of patients
• Hair loss (alopecia): reported by approximately 3% of patients

Gastrointestinal side effects: Nausea and beyond

Gastrointestinal side effects are the most frequently reported issue with Wegovy. They occur because semaglutide slows gastric emptying, the rate at which food leaves the stomach. This makes you feel full for longer but can cause nausea, bloating, and discomfort, particularly in the early weeks of treatment.

How long does nausea last on Wegovy?

For most patients, nausea is transient. It is typically most intense in the first two to three days after a dose increase and usually settles within two to four weeks as the body reaches a steady state at that dose.

Tips to manage gastrointestinal side effects

• Eat smaller portions. Stop eating the moment you feel full. Overeating is a primary trigger for nausea and vomiting on Wegovy.
• Choose bland foods. Crackers, toast, or rice are easier to tolerate if you are feeling nauseous.
• Stay upright after meals. Avoid lying down immediately after eating to reduce acid reflux.
• Stay hydrated. Sip water or ginger tea throughout the day. Dehydration significantly worsens nausea.

Wegovy and hair loss: Is it real?

Some patients experience hair thinning on Wegovy, but it is rarely caused directly by the drug itself. The more common explanation is a condition called telogen effluvium, a temporary form of hair shedding triggered by rapid weight loss or significant metabolic change.

Why hair loss happens

When the body undergoes a significant caloric deficit or rapid weight loss, it enters a protective metabolic state, prioritising essential organs and diverting nutrients away from structures like hair follicles. This shifts a large number of follicles from the growth phase (anagen) into the resting phase (telogen) simultaneously. Because hair grows in cycles, the thinning you notice is often the result of a metabolic change that occurred three to four months earlier.

Is it permanent?

It is important to distinguish telogen effluvium from male or female pattern baldness. The hair follicle itself remains healthy; it is simply resting. In almost all cases, hair regrows once the body adjusts to its new weight and nutritional balance is restored.

What helps

Ensuring adequate protein intake (60 to 80 g of high-quality protein daily is a reasonable target, as hair is primarily composed of keratin) and maintaining sufficient levels of iron, zinc, vitamin D, and ferritin can support the regrowth cycle.

Can Wegovy cause depression or mood changes?

As of April 2026, large-scale reviews by both the EMA and the MHRA have not established a causal link between Wegovy and depression or suicidal thoughts. Monitoring in this area remains ongoing, and it is an area the MHRA continues to review through post-marketing surveillance.

While clinical trials did not show a higher rate of depression in Wegovy users compared to placebo, some patients report feeling emotionally flat or experiencing a reduced sense of pleasure around food. Because food is often a source of comfort and social connection, losing that relationship can affect mood in ways that are worth acknowledging and discussing with your prescriber.

Wegovy side effects and alcohol

There is no direct chemical interaction between Wegovy and alcohol, but combining the two can be problematic. Alcohol is a gastric irritant and can significantly worsen Wegovy's gastrointestinal side effects.

Wegovy headache: Causes and management

Headaches affect approximately 14% of patients in clinical trials and are most frequently reported during the first few weeks of treatment or shortly after a dose increase. Most Wegovy-related headaches are not caused directly by the medication but by secondary factors.

Dehydration

Because Wegovy can suppress thirst and cause nausea or diarrhoea, it is easy to become mildly dehydrated, which is a primary trigger for headaches.

Low blood sugar

As calorie intake decreases, blood sugar levels may fluctuate, leading to tension-type headaches.

Caffeine reduction

Many people naturally reduce their coffee or tea intake when starting Wegovy, which can trigger withdrawal headaches in regular caffeine drinkers.

Management tips

• Aim for at least 2 litres of water daily
• Eat small, regular meals to keep blood sugar stable
• Standard over-the-counter pain relief such as paracetamol is generally effective for mild headaches
• For persistent headaches, an electrolyte drink can help restore hydration balance more effectively than water alone

Wegovy and cancer risk: Putting it in context

In rodent studies, semaglutide caused a dose-dependent increase in thyroid C-cell tumours. This is a class effect observed across GLP-1 receptor agonists as a group. Importantly, this risk has only ever been observed in animals. Rats have a much higher concentration of GLP-1 receptors in their thyroids than humans, which means the animal findings do not automatically translate. No link between Wegovy and thyroid tumours in humans has been established, and research is ongoing.

As a precaution, Wegovy must not be used by anyone with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia type 2 (MEN 2).

Warning

If you notice a lump in your neck, persistent hoarseness, or difficulty swallowing while taking Wegovy, contact your GP promptly and let them know you are taking semaglutide.

Long-term side effects of Wegovy: What is known?

The long-term safety profile of Wegovy continues to be updated as real-world data and extended study results become available. Evidence for its safety and efficacy is currently established for up to four years of continuous use.

Established long-term benefits

The SELECT trial (2023) demonstrated that long-term use of semaglutide, over up to 40 months, reduces the risk of major adverse cardiovascular events by 20% in adults with established heart disease and overweight or obesity. The STEP 5 trial (2022) confirmed sustained weight management over two years, with most side effects remaining gastrointestinal and occurring early in treatment. Chronic use is also associated with meaningful improvements in blood sugar control, blood pressure, and cholesterol levels.

Areas of ongoing research

While Wegovy is well-studied relative to most treatments of its age, areas still under observation include the long-term impact on bone density and muscle mass over extended treatment periods.

Do the side effects of Wegovy go away?

Most patients find that side effects follow a predictable pattern and subside over time. Because Wegovy is a dose-escalating medication, the body effectively adjusts to a new dose level every four weeks until the maintenance dose is reached.

Serious side effects: When to seek help

While rare, some side effects require immediate medical attention. Call 999 or go to A&E if you experience any of the following.

Red flag symptoms

• Acute pancreatitis: Severe, persistent abdominal pain that radiates to the back, often accompanied by nausea and vomiting. Do not wait to see if it improves.
• Severe allergic reaction (anaphylaxis): Swelling of the face, lips, tongue, or throat, or difficulty breathing.
• Gallbladder problems: Sharp pain in the upper right abdomen, yellowing of the skin or eyes (jaundice), or fever.
• Severe dehydration: Inability to pass urine, extreme thirst, or confusion.

Final thoughts

Wegovy is a powerful medicine that works best with proper clinical support behind it. While the list of potential side effects can seem daunting, most UK patients find them manageable relative to the significant health benefits that meaningful weight loss delivers. The key to a successful journey is staying in close contact with your prescriber throughout. Never tough out worsening symptoms alone.

FAQ